S&P 500   4,567.60 (+0.28%)
DOW   35,544.55 (+0.36%)
QQQ   391.32 (+0.29%)
AAPL   189.83 (-0.30%)
MSFT   378.51 (-1.09%)
META   333.77 (-1.54%)
GOOGL   135.75 (-1.06%)
AMZN   146.39 (-0.44%)
TSLA   248.89 (+0.88%)
NVDA   482.22 (+0.84%)
NIO   7.24 (+0.42%)
BABA   74.77 (-2.57%)
AMD   124.65 (+2.16%)
T   16.24 (+0.37%)
F   10.66 (+2.80%)
MU   77.36 (+1.63%)
CGC   0.55 (+1.78%)
GE   119.43 (+0.49%)
DIS   92.78 (+0.30%)
AMC   7.06 (+5.37%)
PFE   30.04 (+1.18%)
PYPL   58.58 (+0.19%)
XOM   103.25 (-0.63%)
S&P 500   4,567.60 (+0.28%)
DOW   35,544.55 (+0.36%)
QQQ   391.32 (+0.29%)
AAPL   189.83 (-0.30%)
MSFT   378.51 (-1.09%)
META   333.77 (-1.54%)
GOOGL   135.75 (-1.06%)
AMZN   146.39 (-0.44%)
TSLA   248.89 (+0.88%)
NVDA   482.22 (+0.84%)
NIO   7.24 (+0.42%)
BABA   74.77 (-2.57%)
AMD   124.65 (+2.16%)
T   16.24 (+0.37%)
F   10.66 (+2.80%)
MU   77.36 (+1.63%)
CGC   0.55 (+1.78%)
GE   119.43 (+0.49%)
DIS   92.78 (+0.30%)
AMC   7.06 (+5.37%)
PFE   30.04 (+1.18%)
PYPL   58.58 (+0.19%)
XOM   103.25 (-0.63%)
S&P 500   4,567.60 (+0.28%)
DOW   35,544.55 (+0.36%)
QQQ   391.32 (+0.29%)
AAPL   189.83 (-0.30%)
MSFT   378.51 (-1.09%)
META   333.77 (-1.54%)
GOOGL   135.75 (-1.06%)
AMZN   146.39 (-0.44%)
TSLA   248.89 (+0.88%)
NVDA   482.22 (+0.84%)
NIO   7.24 (+0.42%)
BABA   74.77 (-2.57%)
AMD   124.65 (+2.16%)
T   16.24 (+0.37%)
F   10.66 (+2.80%)
MU   77.36 (+1.63%)
CGC   0.55 (+1.78%)
GE   119.43 (+0.49%)
DIS   92.78 (+0.30%)
AMC   7.06 (+5.37%)
PFE   30.04 (+1.18%)
PYPL   58.58 (+0.19%)
XOM   103.25 (-0.63%)
S&P 500   4,567.60 (+0.28%)
DOW   35,544.55 (+0.36%)
QQQ   391.32 (+0.29%)
AAPL   189.83 (-0.30%)
MSFT   378.51 (-1.09%)
META   333.77 (-1.54%)
GOOGL   135.75 (-1.06%)
AMZN   146.39 (-0.44%)
TSLA   248.89 (+0.88%)
NVDA   482.22 (+0.84%)
NIO   7.24 (+0.42%)
BABA   74.77 (-2.57%)
AMD   124.65 (+2.16%)
T   16.24 (+0.37%)
F   10.66 (+2.80%)
MU   77.36 (+1.63%)
CGC   0.55 (+1.78%)
GE   119.43 (+0.49%)
DIS   92.78 (+0.30%)
AMC   7.06 (+5.37%)
PFE   30.04 (+1.18%)
PYPL   58.58 (+0.19%)
XOM   103.25 (-0.63%)

Aclarion Stock Price, News & Analysis (NASDAQ:ACON)

$0.26
-0.01 (-2.96%)
(As of 12:29 PM ET)
Compare
Today's Range
$0.26
$0.30
50-Day Range
$0.26
$0.57
52-Week Range
$0.25
$2.37
Volume
29,698 shs
Average Volume
765,644 shs
Market Capitalization
$2.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ACON stock logo

About Aclarion Stock (NASDAQ:ACON)

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in Broomfield, Colorado.

ACON Stock Price History

ACON Stock News Headlines

Short Interest in Aclarion, Inc. (NASDAQ:ACON) Expands By 59.7%
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Aclarion Inc.
Why Aclarion Stock Is Popping Today
Aclarion, Inc. Announces Delayed 10-Q Filing
Aclarion gets $2M debt financing
Why Aclarion Shares Are Soaring Today
See More Headlines
Receive ACON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aclarion and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
11/29/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/13/2024

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ACON
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-7,070,000.00
Net Margins
-5,433.03%
Pretax Margin
-5,431.85%

Debt

Sales & Book Value

Annual Sales
$60,000.00
Book Value
$0.28 per share

Miscellaneous

Free Float
6,832,000
Market Cap
$2.32 million
Optionable
Not Optionable
Beta
1.48
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report














ACON Stock Analysis - Frequently Asked Questions

How have ACON shares performed in 2023?

Aclarion's stock was trading at $0.58 at the beginning of the year. Since then, ACON shares have decreased by 54.8% and is now trading at $0.2621.
View the best growth stocks for 2023 here
.

Are investors shorting Aclarion?

Aclarion saw a increase in short interest in November. As of November 15th, there was short interest totaling 35,300 shares, an increase of 59.7% from the October 31st total of 22,100 shares. Based on an average daily volume of 172,400 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.7% of the company's shares are sold short.
View Aclarion's Short Interest
.

When is Aclarion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024.
View our ACON earnings forecast
.

When did Aclarion IPO?

(ACON) raised $12 million in an initial public offering (IPO) on Friday, April 22nd 2022. The company issued 2,165,000 shares at $4.50-$6.50 per share.

How do I buy shares of Aclarion?

Shares of ACON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:ACON) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -